resTORbio Inc (TORC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

resTORbio Inc (resTORbio) a subsidiary of Puretech Health plc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of aging-related diseases. Its pipeline product candidate RTB101, an orally administered, small molecule, potent TORC1 inhibitor alone or in combination with everolimus used for the treatment of respiratory tract infections, autophagy-related diseases. resTORbios lead program is selectively targeting TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiovascular and central nervous systems. resTORbio is headquartered in Boston, Massachusetts, the US.

resTORbio Inc (TORC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
resTORbio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
resTORbio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
resTORbio Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
resTORbio Raises USD40 Million in Series B Financing 10
resTORbio Raises USD25 Million in Series A Financing 12
Equity Offering 13
resTORbio Raises USD97.8 Million in IPO of Shares 13
resTORbio Inc - Key Competitors 14
resTORbio Inc - Key Employees 15
resTORbio Inc - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Aug 09, 2018: resTORbio reports second quarter 2018 financial results 17
May 10, 2018: resTORbio Reports First Quarter 2018 Financial Results 19
Mar 29, 2018: resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results 20
Corporate Communications 21
Jan 03, 2018: PureTech Health Affiliate resTORbio Adds Lynne Sullivan, Biogen Senior Vice President, to Board of Directors 21
Jan 03, 2018: resTORbio Appoints Lynne Sullivan to Its Board of Directors 22
Dec 11, 2017: resTORbio Appoints Paul Fonteyne to its Board of Directors 23
Product News 24
12/11/2017: resTORbio Appoints Paul Fonteyne to its Board of Directors 24
03/19/2018: resTORbio Announces Formation of Clinical Advisory Board 25
Clinical Trials 27
Jul 25, 2018: PureTech Health Affiliate resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101 27
Jul 11, 2018: resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older 29
May 22, 2018: resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition 30
May 09, 2018: resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly 31
Nov 20, 2017: PureTechs resTORbio Advances Immunotherapy Candidate for Aging-Related Conditions Following Recommendation from Independent Data Monitoring Committee 32
May 09, 2017: PureTech Health Announces Initiation of Phase 2b mTORC1 Inhibitors Study in Elderly Patients at Increased Risk of Respiratory Tract Infections 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables


resTORbio Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
resTORbio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
resTORbio Inc, Deals By Therapy Area, 2012 to YTD 2018 8
resTORbio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
resTORbio Raises USD40 Million in Series B Financing 10
resTORbio Raises USD25 Million in Series A Financing 12
resTORbio Raises USD97.8 Million in IPO of Shares 13
resTORbio Inc, Key Competitors 14
resTORbio Inc, Key Employees 15

List Of Figures


resTORbio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
resTORbio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
resTORbio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

resTORbio Inc (TORC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

resTORbio Inc (resTORbio) a subsidiary of Puretech Health plc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of aging-related diseases. Its

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available